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Proteomics and Metabolite Analysis Reveals the Role of hnRNP K in HK2
Cells
L. Q. H. He, Z. J. W. Wang, Q. S. Sun, Z. M. T. Tian
The Key Laboratory of Biomedical Information Engineering of Ministry of
Education, School of Life Science and Technology, Xi’an Jiaotong University,
Xi’an, China
Background: Salt sensitive hypertension is a kind of metabolic syndrome.
hnRNP K was up-regulated in renal medulla of salt resistant rats, but
down-regulated in salt sensitive rats and the latter developed hypertension.
The function of hnRNP K in renal cells of salt sensitive hypertension rats is
not fully understood.
Methods: Proteomics and metabolomics profiling, Western blot, biochem-
istry analysis and ATP generation rate detection were used to figure out
the globe regulatory functions of hnRNP K in HK2 cells through siRNA knock-
down technology.
Results: The proteomics analysis indicated that the expression of multiple en-
zymes inmitochondrial were increasedwhile hnRNPKwas knockeddown, such
as MDH, PDH ,ɑ-KGDH, NADH dehydrogenase, cytochrome b-c1 complex, cyto-
chrome c and ATP synthase, of which, MDH, PDH , cytochrome c were further
verified by western blot. The activities of MDH, FH, ɑ-KGDH and mitochondria
NADP-ICDwere also increased. Boinformatic analysis revealed that glycolysis/
gluconeogenesis was decreased and TCA and oxidative phosphorylation
pathway were significantly increased. The results suggested that the function
of mitochondrial improved, which were confirmed by the increasing of mem-
brane potential and ATP generation rate when hnRNP K was knocked down.
Further detection of metabolic intermediates by GC/MS showed succinate,
malate, lactate acid, 11 amino acids which could transform to substrates of
TCAwere decreased in hnRNP K knockdown cells except pyruvate. The change
of metabolic compounds confirmed the results of bioinformatic analysis.
Conclusion: Consequently, current research work demonstrated that down-
regulated hnRNP K contributes to enhanced protein expression of the TCA
cycle and oxidative phosphorylation, but depresses glycolysis/gluconeogen-
esis in kidney cells. These data also suggested that the regulatory function of
hnRNP K to metabolism of mitochondrial could be involved in the develop-
ment of salt induced hypertension.http://dx.doi.org/10.1016/j.hkjn.2015.08.0750117
Hypertension in Non-dialysis CKD Patients in China
Ying Zheng, Guangyan Cai, Xiangmei Chen
Chinese PLA General Hospital, Beijing, China
Objective: The aim of the present study was to investigate the prevalence,
awareness, treatment, and control of hypertension in the non-dialysis CKD
patients through a nationwide, multicenter study in China.
Methods: The survey was performed in 61 tertiary hospitals in 31 provinces,
municipalities, and autonomous regions in China (except Hong Kong, Macao,
and Taiwan). Trained physicians collected demographic and clinical data and
measured blood pressure (BP) using a standardized protocol. Antihyperten-
sive drugs were classified into a single category and the percent of every
category were counted. Resistant hypertension was defined as BP above
the target BP (< 140/90 mmHg) despite the use of 3 antihypertensive drugs
or achieving the target BP by using  4 antihypertensive drugs.
Results: The analysis included 8927 non-dialysis CKD patients. The preva-
lence, awareness, and treatment of hypertension in non-dialysis CKD pa-
tients were 67.3%, 85.8%, and 81.0%, respectively. Of hypertensive CKD
patients, 33.1% had controlled BP to < 140/90 mmHg. In 4435 participants
who had records of antihypertensive treatment, 36.9% achieved hyperten-
sion control, 11.1% met the criteria for resistant hypertension and 52.0%
used  2 antihypertensive drugs and were uncontrolled.
Conclusion: The prevalence of hypertension Chinese non-dialysis CKD patients
was high, and the hypertension control was suboptimal. Compared to resistant
hypertension, the inadequate use of antihypertensive drugs appeared to
contribute more to the lack of hypertension control in CKD patients.http://dx.doi.org/10.1016/j.hkjn.2015.08.0760205
Role of Mitochondrial Dysfunction and ROS Production in Ang II-induced
NLRP3 Inflammasome Activation
Wen Yi, Liu YR, Tang TT, Liu B.C.
Southeast University, Nanjing, China
Objective: The type 1 angiotensin (AT1) receptor plays an important role in
maintaining blood pressure. Previous studies suggested that the activation of
immune responses by angiotensin (Ang) II during hypertension may aggravate
renal damage. NLRP3 inflammasome activation promotes renal inflammation
and contributes to chronic kidney damage. Further investigation should be
performed to explore the correlation between the RAS and NLRP3 inflamma-
some activation, and possible mechanisms.
Methods: C57BL/6 AT1R-/- and NLRP3-/- mice underwent left nephrectomy
followed 1 week for recovery. Blood pressure measurements were recorded
at baseline and following 4 weeks of chronic Ang II or saline infusion. At the
end of the experiment, the kidney were harvested and fixed. AT1R siRNA and
mitoTEMPO treatment were performed before the Ang II stimulation in HK2
cells. The expression levels of NLRP3 inflammasome and mitochondrial
dysfunction were measured.
Results: Ang II significantly induced kidney injury and NLRP3 inflammasome
activation. Mitochondria swelling and fragmentation were observed by trans-
mission electron microscope. AT1-/- blocked Ang II-induced hypertension,
inhibiting the mitochondrial dysfunction and NLRP3 expression. Deficiency
of NLRP3 attenuated kidney injury in hypertension with no significant influ-
ence to blood pressure. In vitro studies showed that Ang II stimulation in-
crease the mitochondrial damage and NLRP3 activation in dose- and time-
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MitoTEMPO attenuated the activation of NRLP3 inflammasome through clear-
ance of reactive oxygen species (ROS). Moreover, Ang II-induced mitochon-
drial dysfunction was markedly inhibited by silence of NLRP3.
Conclusion: Ang II stimulation induces NLRP3 inflammasome activation
through AT1a receptor. Ang II-induced NLRP3 activation is mediated by mito-
chondrial dysfunction, with overproduction and accumulation of ROS. NLRP3
inflammasome activation plays an important role in kidney injury, and block-
ing it can be a potential therapeutic target for hypertension-associated kid-
ney damage.http://dx.doi.org/10.1016/j.hkjn.2015.08.0770220
International Congress of Chinese Nephrologists: Clinical and
Pathological Characteristics of 75 Chinese Patients with Benign
Hypertensive Nephrosclerosis
Jia Kou, Yan Zhang, Shuang Liang, Xue-guang Zhang, Guang-yan Cai, Xiang-
mei Chen
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Objective: To Identify the clinical and pathological characteristics of 75 Chi-
nese patients with benign hypertensive nephrosclerosis (BHN) and the rela-
tionship between the clinical and pathological changes.
Methods: BHN patients proved by renal biopsy were retrospectively
analyzed based on the clinical and pathological records. Glomerular lesions
were divided into five types: hypertrophic, focal segmental sclerotic, solid-
ified or ischemic (including wrinkled and obsolescent changes). Patients
were grouped for further analysis according to whether eGFR  60 ml/
min/1.73 m2,  30% ischemic glomeruli,  20% obsolescent glomeruli,
respectively.
Results: 75 BHN patients with an average age of 44.4 10.7 years, M/F 4:1.
eGFR had significant negative correlation with systolic blood pressure (SBP)
(rZ0.276, PZ 0.016) but not diastolic blood pressure (DBP). DBP had sig-
nificant negative correlation with age (rZ0.3, PZ 0.007). The most com-
mon pathological type of glomerular lesion was ischemic (30.6%), including
ischemic wrinkled (13%) and obsolescent (17.6%). Arteriolar stenosis had sig-
nificant positive correlation with ischemic glomerular lesion (rZ 0.33,
PZ 0.004), but not obsolescent glomeruli. Multivariate analysis showed:
(1) SBP rather than DBP was independent risk factor of eGFR decline; (2) in-
dependent associated factors of ischemic glomerular change were TG
(ORZ 1.78, 95% CI 1.02w3.1; PZ 0.041), age (ORZ 0.93, 95% CI
0.89w0.99; PZ 0.018) and eGFR (ORZ 0.97, 95% CI 0.95w0.99;
PZ 0.004); (3) independent associated factors of obsolescent glomeruli
were TG (ORZ 1.96, 95% CI 1.13w3.4; PZ 0.016) and eGFR (ORZ 0.97,
95% CI 0.95w0.99; PZ 0.012).
Conclusion: SBP is independent risk factor of eGFR decline in BHN. TG pro-
moted the development of ischemic and obsolescent glomerular lesion
which may offer a new therapeutic target for the management of BHN.http://dx.doi.org/10.1016/j.hkjn.2015.08.078
0235
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Objective: Chronic kidney disease (CKD) is highly prevalent in Taiwan.
More than two-thirds of end-stage renal disease is associated with diabetes
mellitus (DM) or hypertension (HTN). Therefore, the formulation of aspecial preventative policy of CKD in these patients is essential. This study
surveyed 14 traditional risk factors and identified their effects on CKD in
patients with HTN/DM and compared these with their effects in the gen-
eral population.
Methods: This study included 5328 cases and 5135 controls in the CKD/HTN/
DM outpatient centers of 10 hospitals in Taiwan. Fourteen common effect
factors were surveyed (four demographic, five disease and five lifestyle),
and their effects on CKD were tested. Significance tests were adjusted by
the Bonferroni method. Results of the stratified analyses in the variables
were presented with significant heterogeneity between patients with
different comorbidities.
Results: Male, ageing, low income, hyperuricemia and lack of exercise
habits were risk factors for CKD, and their effects in people with different
comorbidities were identical. Anemia was a risk factor, and there was an ad-
ditive effect between anemia and HTN on CKD. Patients with anaemia had a
higher risk when associated with HTN [odds ratio (OR)Z 6.75, 95% CI
4.76e9.68] but had a smaller effect in people without HTN (OR 2.83, 95%
CI 2.16e3.67). The association between hyperlipidaemia-related factors
and CKD was also moderated by HTN. It was a significant risk factor in people
without HTN (ORZ 1.67, 95% CI 1.38e2.01) but not in patients with HTN
(ORZ 1.03, 95% CI 0.89e1.19). Hepatitis B, hepatitis C, betel nut chewing,
smoking, alcohol intake and groundwater use were not associated with CKD
in multivariate analysis.
Conclusion: We considered that patients with HTN and anemia were a
high CKD risk population. Physicians with anemic patients in outpatient
clinics need to recognize that patients who have HTN might be latent
CKD cases.http://dx.doi.org/10.1016/j.hkjn.2015.08.0790240
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Increases the Risk of Chronic Kidney Disease in a Chinese Population-
based Cohort
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Objective: Chronic kidney disease (CKD) is an independent risk factor for
cardiovascular disease. Although pulse wave velocity (PWV), which reflects
arterial stiffness, was increased in subjects with CKD, little is known
regarding whether arterial stiffness can increase the risk of CKD. To help
clarify this, we conducted a prospective cohort study to measure the associ-
ation of arterial stiffness with CKD.
Methods: A total of 7455 adults who visited the Health Checkup Clinic
consecutively were enrolled from April 2010 to December 2010. 92 partici-
pants with proteinuria, and 108 participants with decreased eGFR calculated
by the CKD-EPI equation (eGFR < 60 ml/min/1.73 m2) at baseline were
excluded. CKD was defined as decreased eGFR or presence of proteinuria
(urine protein  1+). During the follow-up, 43 participants were lost to
follow-up. 58 participants were excluded from ananlysis due to insufficient
blood or urine samples, 7154 participants aged 54.8 10.6 years without
CKD at baseline were enrolled in the final ananlysis. Arterial stiffness was
evaluated by carotid-femoral PWV (cfPWV) using the SphygmoCor device
(AtCor Medical Ltd., Sydney, Australia).
Results: During 3 years of follow-up, 167 (2.3%) patients developed CKD,
101 (1.4%) patients with proteinuria and 68 (1.0%) patients with decreased
eGFR. After adjusting for potential confounders, either cfPWV (per 1cm/s
increase) or the highest quartile of cfPWV (increased cfPWV) was indepen-
dently associated with increased risk of proteinuria and CKD (P< 0.05). By
contrast, neither cfPWV (per 1 cm/s increase) nor increased cfPWV was
associatied with decreased eGFR in the multivariable logistic regression
analysis.
Conclusion: This study revealed that arterial stiffness increases the risk of
CKD. Hence, high-risk patients with arterial stiffness should have targeted
monitoring for the development of CKD.
